CE-224535

DB12113InvestigationalSmall molecule

CE-224535 has been used in trials studying the treatment of Osteoarthritis.

Chemical structure of CE-224535
Mechanism
Curator reviewed
Formula / weight
C22H29ClN4O6 · 480.95 g/mol (avg)
Code names
CE-224,535

Resolves to

Compound
UNIIT8B02RAU3CCAS724424-43-5ChEMBLCHEMBL1823817PubChem11547499
Structure
InChIKeyFUCKCIVGBCBZNP-MRXNPFEDSA-NSMILESCOC[C@H](O)CN1C(=O)C=NN(C1=O)C1=CC=C(Cl)C(=C1)C(=O)NCC1(O)CCCCCC1
Targets
Q99572P2RX7

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with CE-224535, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In